Serious Hyperkalemia (Figure 8)
Serious hyperkalemia was assessed by examining two outcomes: serious
hyperkalemia and hyperkalemia-related hospitalization. The
above-mentioned outcomes were reported in five out of seven studies
[5,10,14-16], and the pooled analysis revealed that treatment with
Finerenone was associated with a significantly increased risk of serious
hyperkalemia and hospitalization due to hyperkalemia (RR = 4.25 [3.11,
5.83] p 0. 00001; I2= 0%) and (RR = 5.94 [4.04, 8.75] p 0. 00001;
I2= 0%), respectively.